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A COMPLEMENTATION ASSAY FOR IN VIVO PROTEIN
STRUCTURE/FUNCTION ANALYSIS IN PHYSCOMITRELLA PATENS
(FUNARIACEAE)1
TESS R. SCAVUZZO-DUGGAN2, ARIELLE M. CHAVES2, AND ALISON W. ROBERTS2,3
2Department

of Biological Sciences, University of Rhode Island, 120 Flagg Road, Kingston, Rhode Island 02881 USA

• Premise of the study: A method for rapid in vivo functional analysis of engineered proteins was developed using Physcomitrella
patens.
• Methods and Results: A complementation assay was designed for testing structure/function relationships in cellulose synthase
(CESA) proteins. The components of the assay include (1) construction of test vectors that drive expression of epitope-tagged
PpCESA5 carrying engineered mutations, (2) transformation of a ppcesa5 knockout line that fails to produce gametophores
with test and control vectors, (3) scoring the stable transformants for gametophore production, (4) statistical analysis comparing complementation rates for test vectors to positive and negative control vectors, and (5) analysis of transgenic protein expression by Western blotting. The assay distinguished mutations that generate fully functional, nonfunctional, and partially
functional proteins.
• Conclusions: Compared with existing methods for in vivo testing of protein function, this complementation assay provides a
rapid method for investigating protein structure/function relationships in plants.
Key words: cellulose synthase; complementation assay; gametophore development; Physcomitrella patens; protein structure/
function relationships.

Protein structure/function relationships can be investigated
using a structural model to generate hypotheses and an in vitro
reconstitution assay for functional analysis of protein variants.
However, this approach is only available for some proteins. For
example, elucidation of the structure/function relationships for
bacterial cellulose synthases has progressed due to two recent
technical advances—solving of the crystal structure of Rhodobacter sphaeroides (van Niel 1944) Imhoff et al. 1984 cellulose synthase (Morgan et al., 2013) and in vitro reconstitution
of functional cellulose synthase from purified R. sphaeroides
proteins (Omadjela et al., 2013). A computational model for the
cytoplasmic region of a plant cellulose synthase (designated
CESA) from Gossypium hirsutum L. (Sethaphong et al., 2013) has
been used to postulate functions of the structural features that
distinguish CESAs from bacterial cellulose synthases (Slabaugh
et al., 2014a). However, methods for routine in vitro assay of

CESA activity are not available for functional testing (Guerriero
et al., 2010).
In vivo complementation assays provide alternatives to in
vitro assays for protein functional analysis. This approach was
used effectively to test an engineered point mutation in an Arabidopsis thaliana (L.) Heynh. CESA that was predicted to impair protein function based on computational modeling (Slabaugh
et al., 2014b). However, due to the time and space required for
genetic transformation and backcrossing, A. thaliana is not ideal
for screening large numbers of mutations. As in all mosses, the
protonema and gametophores of Physcomitrella patens (Hedw.)
Bruch & Schimp. are haploid. Thus, mutant phenotypes can be
detected immediately without the need for backcrossing to produce homozygous diploid lines. This makes P. patens a faster
alternative to A. thaliana for assays that involve genetic transformation (Cove, 2005; Cove et al., 2006).
Physcomitrella patens cell walls contain the same classes of
polysaccharides as vascular plant cell walls, with some differences in side-chain structure (Roberts et al., 2012). Also, P. patens has rosette cellulose synthesis complexes (Roberts et al.,
2012) and seven CESA genes (Roberts and Bushoven, 2007).
However, consistent with the absence of lignified vascular tissue in mosses, the PpCESA genes are not orthologous to the
CESA genes that synthesize primary and secondary cell walls in
seed plants (Roberts and Bushoven, 2007). We have previously
generated ppcesa5 knockout lines that are deficient in gametophore production. In these lines, the gametophore buds typically produce irregular clumps of tissue, but occasionally form
aberrant gametophores consisting of a few small deformed
leaves with irregular phyllotaxy (Goss et al., 2012). When
transformed with a vector that drives constitutive expression of
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the wild-type PpCESA5 protein, these lines produces normal
gametophores (Goss et al., 2012). This provides a platform for
developing a complementation assay to test CESA proteins that
have been modified by site-directed mutagenesis with the extent of rescue of the mutant phenotype providing a measure of
protein function.
Here we describe a complementation assay in P. patens for
analysis of structure/function relationships in plant CESA proteins that is rapid and has modest space requirements. Although
designed for analysis of CESA proteins, this assay could be
adapted to study structure/function relationships of other proteins where the knockout phenotype can be easily scored.
METHODS AND RESULTS
Vector construction and ppcesa5KO-2 transformation—Expression vectors carrying a wild-type (positive control) or a mutated (test) PpCESA5 coding
sequence fused at the N-terminus to a triple hemagglutinin (3XHA) epitope tag
were constructed using PCR fusion and MultiSite Gateway cloning (Atanassov
et al., 2009). To create Gateway entry clones carrying point mutations, gene
fragments were amplified from wild-type PpCESA5 cDNA clone pdp24095
(RIKEN BioResource Center, http://www.brc.riken.jp/lab/epd/Eng/) using
primer pairs that added an att site at one end and introduced a mutation at the
other (Appendix 1; Appendix 2, Fig. A1, A2). The fragments were fused in a
single overlap extension reaction (Appendix 2) and cloned into pDONR 221
P5-P2 according to the manufacturer’s instructions (Life Technologies, Grand
Island, New York, USA). CESA5 entry clones were sequence verified using
primers listed in Appendix 3. To create the 3XHA entry clone, two oligonucleotides (Appendix 1) were fused, cloned into pDONR 221 P1-P5r (Life Technologies), and sequence verified using primer M13 Forward (−20) (Life
Technologies). Each CESA5 entry clone was transferred along with a 3XHA
entry clone to the pTHAct1Gate destination vector using LR Clonase II Plus as
described by the manufacturer (Life Technologies). The pTHAct1Gate vector
contains an Act1 promoter from rice, which drives constitutive expression in
P. patens, and sequences that target the vector to the P. patens 108 locus, which
can be disrupted without producing a phenotype (Perroud and Quatrano, 2006).
Protoplasts prepared from mutant P. patens line ppcesa5KO-2 (Goss et al.,
2012) were divided into five or six samples (6 × 105 protoplasts each) and each
sample was transformed with a test (R453K, R453D, or R453G), positive wildtype CESA5 expression, or empty pTHAct1 negative control vector (Table 1),
following the detailed protocol of Roberts et al. (2011). Regenerated protoplasts were subjected to two rounds of selection (Roberts et al., 2011), which
typically resulted in 10–40 vigorously growing, stably transformed lines for
each vector (Appendix 2, Fig. A3). Results from an experiment (i.e., five to six
transformations using the same batch of protoplasts) were excluded from the
statistical analysis when fewer than 10 lines were obtained for the positive or
negative control transformations. In cases where one or more test vectors from
an otherwise successful experiment yielded fewer than 10 lines, results from
only those test vectors were excluded. Isolated colonies, each comprising an
independent stably transformed line, were arrayed on solid BCDAT plates
(Roberts et al., 2011) and incubated in a growth chamber at 25°C with fluorescent lights at a photon flux density of 60 μM m−2s−1 for 7 d.
Complementation analysis—To make the assay as rapid as possible, we
evaluated phenotypes using primary colonies derived from independently
transformed protoplasts and selected for stable antibiotic resistance. In contrast
to tissue subcultured from wild-type and mutant lines, the positive and negative

TABLE 1.
Name
CESA5
Empty
R453K
R453G
R453D
a Zhong

Expression vectors used to transform Physcomitrella patens.
Expression cassette

Comments

Act1::3XHA-PpCESA5
None
Act1::3XHA-ppcesa5-R453K
Act1::3XHA-ppcesa5-R453G
Act1::3XHA-ppcesa5-R453D

Positive control
Negative control
Homologous to fra6a
Variant of R453K
Variant of R453K

et al., 2003.
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control transformations produced multiple colonies, each representing an independent stably transformed line, that could be directly and quantitatively compared to colonies derived from test transformations. Comparisons were based
on the percentage of stably transformed lines that produced gametophores and
on gametophore morphology. A dissecting microscope (Meiji EMZ-TR, Meiji
Techno Co. Ltd., Tokyo, Japan) was used at 30× to count the number of lines
with and without gametophores. Colonies and individual gametophores were
photographed using a stereomicroscope (Leica M165 FC with Leica BFC310
FX camera, Leica Microsystems, Buffalo Grove, Illinois, USA), and individual
leaves were photographed using a compound microscope (Olympus BX51,
Olympus Corporation, Lake Success, New York, USA) with a Spot Flex camera (Diagnostic Instruments, Sterling Heights, Michigan, USA). The positive
control CESA5 vector complemented the ppcesa5KO-2 phenotype, with 78% ±
3.8% of lines (average for seven independent transformations: 138 stably transformed lines) producing gametophores that generally resembled wild-type gametophores (Fig. 1A). When ppcesa5KO-2 was transformed with the empty
negative control vector, only 13% ± 4.9% of lines (average for seven independent transformations: 182 stably transformed lines) produced gametophores.
These were distinctly abnormal with fewer than 10 small misshapen leaves and
abnormal phyllotaxy (Fig. 1A) and resembled those that are produced at low
frequency by the untransformed ppcesa5KO-2 line (Goss et al., 2012). Fewer
than 10% of stable lines produced gametophores in a typical negative control
transformation, and even when the percentage was higher the gametophores
were never normal in appearance. To ensure consistency, colonies were scored
for presence and absence of gametophores without considering gametophore
morphology. Statistical analysis (see below) confirmed that this was adequate
for distinguishing test vectors that complemented or failed to complement the
mutant phenotype. However, deviations from expected morphologies were recorded, and this information was used to identify vectors that partially complemented the mutant phenotype (see below).
We tested the complementation assay with expression vectors carrying the
PpCESA5 coding sequence with three different point mutations at R453 (Table 1).
The R453K mutation is homologous to fra6, a recessive mutation in A. thaliana
(AtCESA8, R362K) that results in decreased fiber wall thickness and cellulose
content, but has a less severe phenotype compared to other atcesa8 mutant
alleles (Zhong et al., 2003). Although AtCESA8 expression is correlated with
secondary cell wall deposition and fra6 is defective in fiber development, the
affected residue is conserved (Zhong et al., 2003). Thus, the phenotypes for
homologous mutations in different CESA genes would be expected to depend
on the developmental function of the mutated CESA. When the ppcesa5KO-2
line was transformed with the R453K expression vector, the percentage of stable
lines producing gametophores was intermediate between the positive and negative control and gametophore morphology was similar to wild type (Fig. 1).
When the basic polar R453 residue was instead replaced with an acidic polar D
residue (R453D), all stable lines lacked gametophores (Fig. 1). Finally, replacement of R453 with a nonpolar G residue (R453G) yielded results similar to the
positive control for both percentage of stable lines with gametophores and
gametophore morphology (Fig. 1).
Statistics and experimental analysis—A two-tailed Fisher’s exact test of
independence (Sokal and Rohlf, 1981) was used for statistical analysis of complementation. Statistics were calculated using the 2 × 2 contingency table at
http://vassarstats.net/tab2x2.html and sample calculations were verified manually. We first confirmed that the numbers of colonies with and without gametophores were significantly different for the CESA5 positive control and the
empty negative control vectors (P < 0.0001, pooled results from seven experiments). Comparison of each test vector to the positive and negative controls
using counts pooled from two or three transformations (Fig. 1B) showed that
R453K and R453D differed significantly from the positive control (P < 0.0001),
but not the empty negative control vector (P = 0.27 and P = 0.50, respectively). In contrast, R453G differed significantly from the negative control
(P < 0.0001), but not the CESA5 positive control vector (P = 0.14). Although
R453K did not differ significantly from the negative control vector in the numbers of colonies with and without gametophores, the gametophores that were
produced resembled those observed following transformation with the CESA5
positive control vector (Fig. 1A), indicating that the encoded protein may be
partially functional. The vectors tested fall into three classes (1) R453G fully
complements, (2) R453D does not complement, and (3) R453K partially complements the cesa5KO-2 phenotype. Thus, this relatively rapid assay allows us
to screen mutations and tentatively identify those that generate functional, nonfunctional, and partially functional proteins. Because these three classes of mutations could be distinguished based on statistical comparison to positive and
negative controls, we were able to streamline the assay by not genotyping the
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Fig. 1. Functional analysis of engineered CESA proteins by complementation in Physcomitrella patens. A. Colonies, gametophores, and gametophore
leaves from lines resulting from stable transformation of ppcesa5KO-2 protoplasts transformed with a vector driving expression of wild-type PpCESA5
(positive control), an empty vector control or vectors driving expression of PpCESA5 carrying engineered point mutations (R453K and R453G). Scale bars
shown in the first column apply to all images in the row. B. ppcesa5KO-2 complementation rates for vectors driving expression of PpCESA5 carrying
engineered point mutations compared to positive and negative control vectors from the same experiment. Means for two (R453K and R453D) or three
(R453G) experiments are shown with P values determined using a two-tailed Fisher’s exact test of independence.

stable transformants. The failure of gametophore production in 12–39% of the
stable lines from transformation with the positive control CESA5 vector can
potentially be explained by (1) disruption of the promoter or coding sequence
of the vector during integration, which would result in lack of transgene expression, or (2) disruption of another locus that is necessary for gametophore
development due to mistargeting of the vector, which would explain lack of
complementation when protein expression is detected (see below). This is supported by the observation that transformation of P. patens with a gene disruption library resulted in a high proportion of lines with gametophore defects
(Egener et al., 2002). These mistargeting events are stochastic (Kamisugi et al.,
2006), and statistical analysis confirms that they do not interfere with the ability
to distinguish complementing from noncomplementing vectors and partially
complementing vectors.
Protein determination—Before concluding that a specific mutation impairs
the function of an encoded protein, it is necessary to rule out lack of expression
of the full-length transgenic protein as an explanation for failure of the vector
to complement the mutant phenotype. This was tested by Western blot analysis
of microsomal proteins isolated from arbitrarily selected stable lines representing a small proportion of lines tested for complementation (see Appendix 2 for
protein extraction methods). Equal masses of protein extracted from 13 stable
CESA5 positive control lines, or 12 stable lines transformed with a particular
test vector along with one CESA5 positive control line, were separated by polyacrylamide gel electrophoresis (PAGE) and transferred to membranes for total
protein detection with Ponceau S and immuno-detection of hemagglutinin (HA)–
tagged protein as described in Appendix 2. As shown in Fig. 2, we tested different protein loadings and found that 7 μg per lane was sufficient for detecting
expression of the transgenic protein. Of 13 CESA5 positive control lines tested,
11 produced an HA-tagged protein with the expected molecular mass of 122
kDa (Fig. 2). The two lines in which the transgenic protein was not detected
failed to produce gametophores (Fig. 2). However, two lines that expressed the
full-length protein also failed to produce gametophores, possibly due to mistargeting of the expression vector to a separate locus required for gametophore
development. These data also show that successful complementation occurs
over a range of protein expression levels. Full-length transgenic protein was
detected in 11 of the 12 lines transformed with R453G or R453K. As noted for
CESA5, transgenic protein was undetectable in some, but not all, of the lines
that failed to produce gametophores (Fig. 2). Although none of the stable lines

http://www.bioone.org/loi/apps

transformed with R453D produced gametophores, all of the 12 lines tested produced a full-length transgenic protein (Fig. 2). These results rule out lack of
expression as an explanation for the failure of the R453D protein to complement the mutant phenotype. Thus, it can be concluded that, in contrast to the
wild-type CESA5 and R453G proteins, the R453D protein is nonfunctional.
Because (1) transgenic protein is strongly expressed in a high proportion of
stably transformed lines and (2) the wild-type CESA5 protein complements the
mutant phenotype over a range of protein expression levels, detailed quantitative analysis of protein expression is not required for detection of mutations that
impair protein function.
Comparison to other methods—Complementation assays provide means to
test hypotheses about the functions of specific proteins and protein modifications and are particularly useful when a robust in vitro assay is not available, as
is the case for CESA proteins (Guerriero et al., 2010). Arabidopsis thaliana has
been used previously for genetic analysis of engineered CESA variants (Wang
et al., 2006; Chen et al., 2010; Bischoff et al., 2011; Slabaugh et al., 2014b).
However, P. patens has the advantages that transformation, selection, and scoring can be completed in 33 d and less space is required to maintain cultures. In
A. thaliana, production of transformants requires three months (Zhang et al.,
2006), with additional time needed for backcrossing to obtain homozygous
lines. Because the dominant phase of the P. patens life cycle is haploid, backcrossing in unnecessary.
In P. patens, an assay has been developed for using image analysis to screen
for mutants that affect protonemal growth and to test for transient complementation of those phenotypes (Bibeau and Vidali, 2014). In contrast to this highly
sensitive assay for detecting protonemal growth defects, the assay reported here
is suitable for analysis of proteins involved in other aspects of P. patens development. It is common practice to use complementation analysis to verify
knockout phenotypes in P. patens, and cross-species complementation has been
used to test for functional conservation of vascular plant and P. patens proteins
(e.g., Bravo-Garcia et al., 2009). Here we have described a systematic approach
for quantitative analysis of complementation based on comparison to positive
and negative controls that can be used for functional testing of heterologous
genes, as well as engineered mutations.
An effective complementation assay is based on a mutant with a measurable
phenotype that is easy to score. The absence of normal gametophores in the
ppcesa5KO mutants (Goss et al., 2012) is readily observed with a dissecting
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allowing classification of engineered proteins as either fully
functional, partially functional, or nonfunctional, (3) engineering
of genes through PCR fusion without introduction of restriction
or recombination sites, (4) epitope-tagging to facilitate testing for
expression of full-length transgenic protein through Western
blotting, and (5) efficiency due to rapid development of P. patens
and no requirements for backcrossing or genotyping. Thus, P.
patens is well suited for rapid identification of mutations, which
can be further investigated in other organisms, if desired.
LITERATURE CITED

Fig. 2. Western blot analysis of protein expression for P. patens lines
derived from transformation of ppcesa5KO-2 protoplasts with vectors driving
expression of wild-type PpCESA5 (positive control) or PpCESA5 carrying engineered point mutation (R453K, R453G, and R453D). Western blots
probed with anti-HA are shown above the same blot stained with Ponceau
S as a loading control. Protein loading per lane was 7.1 μg (PpCESA5),
9.9 μg (R453G), 33 μg (R453K), or 7.4 μg (R453D). Lines that produced
gametophores are indicated by “G,” and those producing no gametophores
are indicated by “g.” Positive (+) and negative (-) control lines are included
with lines from each test transformation.
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statistical analysis comparing test vectors to a positive control vector that drives
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APPENDIX 1.

Primers used in vector construction. The att sites are shown in yellow, start codons are shown in green, stop codon is shown in red, and
engineered mutations are shown in blue.

Primer
CESA5-attB5
CESA5-attB2
R453G-SF1
R453G-SR1
R453K-SF1
R453K-SR1
R453F-SF1
R453F-SR1
3XHA-attB1
3XHA-attB5r

Sequence
5′-GGGGACAACTTTGTATACAAAAGTTGCGATGGAGGCTAATGCAGGCCTTAT-3′
5′-GGGGACCACTTTGTACAAGAAAGCTGGGTACTAACAGCTAAGCCCGCACTCGAC-3′
5′-GTGAAGGAGCGCGGGGCTATGAAGCGA-3′
5′-TCGCTTCATAGCCCCGCGCTCCTTCAC-3′
5′-GTGAAGGAGCGCAAGGCTATGAAGCGA-3′
5′-TCGCTTCATAGCCTTGCGCTCCTTCAC-3′
5′-GTGAAGGAGCGCGATGCTATGAAGCGA-3′
5′-TCGCTTCATAGCATCGCGCTCCTTCAC-3′
5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTCAACCATGGCCTACCCCTACGATGTGCCCGATTACGCCTACCCATACGATGTGCCCGATTACGCT-3′
5′-GGGGACAACTTTTGTATACAAAGTTGTGGCGTAATCGGGCACATCGTAGGGGTAAGCGTAATCGGGCACATCGTATGGGTAGGCGTAATCGGGCACATC-3′
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Benchtop protocol for the Physcomitrella patens complementation assay.

Vector construction
PCR fusion for Gateway: This protocol was modified from Atanassov et al. (2009).
1. Design attB5 and attB2 primers that include the att sites along with sequences from your gene of interest, including the start and stop codons, and SF1 and SR1
primers that include an engineered mutation with about 12 nucleotides upstream and downstream of the mutation (Appendix 1, Fig. A1).
2. Amplify fragments F1 and F2 (Fig. A1) in 50-μL reactions using Phusion DNA polymerase (M0530S, New England Biolabs, Ipswich, Massachusetts, USA)
and recommended cycling conditions. We used a 25-s annealing step at 68°C, but this may need to be adjusted depending on the primers used.
F1 PCR mix:

F2 PCR mix:

10 μL HF Phusion buffer
0.5 μL Phusion enzyme
1 μL dNTP (10 μM)
2 μL CESA cDNA (1–10 ng/μL)
1 μL attB5 primer (25 μM)
1 μL SR1 primer (25 μM)
34.5 μL purified water

10 μL HF Phusion buffer
0.5 μL Phusion enzyme
1 μL dNTP (10 μM)
2 μL CESA cDNA (1–10 ng/μL)
1 μL attB2 primer (25 μM)
1 μL SF1 primer (25 μM)
34.5 μL purified water

Fig. A1. A schematic of site-directed mutagenesis through PCR fusion. Fragments F1 and F2 of the gene of interest are amplified using the
primers attB5 and SR1 and attB2 and SF1, respectively. Fragments F1 and
F2 are combined in a single-cycle PCR fusion reaction to create the mutated gene of interest, which is cloned into pDONR P5-P2 for MultiSite
Gateway cloning. Primers are depicted as arrows, attB sites appear in blue,
coding sequence is in red, and the point mutation appears as a green star.
3. Run 1 μL of each PCR reaction on a gel with a calibrated ladder (Fig. A2) to verify fragment size and estimate DNA concentration.
4. If correct, proceed to PCR fusion with the following caveats:
• Total DNA mass must not exceed 800 ng.
• Add fragments in equimolar amounts. Example: F1 is ~2500 bp and F2 is ~1000 bp, thus 480 ng of F1 and 320 ng of F2 were used (Fig. A2).
PCR Fusion mix:

Thermocycler conditions:

6 μL HF Phusion Buffer
0.3 μL Phusion enzyme
0.3 μL dNTP (10 μM)
F1 and F2 PCR reactions up to 800 ng
Purified water to 30 μL

Hot Start: 98°C
Denaturation: 98°C, 30 s
Annealing: 60°C, 1 min
Extension: 72°C, 7 min

5. PEG purify the PCR fusion product using 30% PEG/MgCl2 included in the Invitrogen MultiSite Gateway Pro (12537-102) or BP Clonase II (11789-020) kit
according to the manufacturer’s instructions (Life Technologies, Grand Island, New York, USA) and resuspend the pellet in 7 μL of TE buffer.
Expression vector construction:
1. Clone the PCR fusion product (3.5 μL) into pDONR P5-P2 in a BP reaction using Invitrogen MultiSite Gateway Pro according to the manufacturer’s instructions (Life Technologies).
2. Transform competent E. coli with 2 μL of the BP reaction and incubate on the appropriate selective medium according to the manufacturer’s instructions (e.g.,
Invitrogen TOP10, Life Technologies).
3. Isolate plasmid DNA from four overnight cultures inoculated with single colonies using a commercial kit according the manufacturer’s instructions (e.g.,
QIAprep Spin Miniprep Kit, QIAGEN, Venlo, The Netherlands).
4. Design and perform restriction digests to identify plasmids containing the expected insert. For the CESA5 entry clones, 2.5 units each of EcoRI-HF and EcoRVHF were used in 20-μL reactions according to the manufacturer’s instructions (New England Biolabs).
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Fig. A2. PCR products separated on a 1% agarose gel (100 V,
25 min). Concentrations of F1 and F2 were both estimated at
~240 ng/μL. However, F1 is ~2500 bp and F2 is ~1000 bp. Thus,
2 μL of PCR reaction F1 was combined with 1.33 μL of PCR
reaction F2 for the PCR fusion reaction.
5. Sequence a plasmid with the expected restriction fragment pattern to verify the mutation and the absence of PCR errors. The primers used to sequence the
CESA5 entry clones are listed in Appendix 3.
6. To create an expression vector, clone the sequence-verified plasmid along with a pDONR P1-P5r entry clone containing an epitope tag (available from the
author) into pTHAct1Gate (available from Pierre-Francois Perroud, Washington University, St. Louis, Missouri, USA) using LR Clonase II Plus as described
by the manufacturer (Life Technologies).
7. Transform competent E. coli with the LR reaction and incubate on the appropriate selective medium as in step 2.
8. Isolate plasmid DNA from four overnight cultures inoculated with single colonies as in step 3.
9. Digest 1 μL of each plasmid prep with 2.5 units of SwaI in a 20-μL reaction according the manufacturer’s instructions (New England Biolabs) to screen for the
expected restriction fragment pattern (2519-bp backbone plus the expression vector of approximately 10,000 bp).
10. Sequence a plasmid with the expected restriction fragment pattern to confirm proper integration of both entry clones into the destination vector. Primer P395
(Appendix 3) was used for expression vectors containing CESA5 entry clones.
Expression vector preparation:
1. Isolate at least 300 μg of plasmid DNA using a commercial midiprep kit (e.g., GenElute HP Plasmid Midiprep Kit [Sigma-Aldrich, St. Louis, Missouri, USA]
or Nucleobond Xtra Midi [Machery-Nagel, Düren, Germany]) or another method.
2. Linearize 100 μg of plasmid DNA with 100 units of SwaI in a 200-μL reaction according the manufacturer’s instructions (New England Biolabs).
3. Ethanol precipitate DNA using sterile technique as described previously (Roberts et al., 2011).
Protoplast isolation and transformation
1. Prepare protoplasts from two plates according to the detailed protocol provided in Roberts et al. (2011) through step 3.3.11 using a P. patens line in which your gene
of interest is knocked out. We have achieved higher regeneration rates when protoplasts were isolated separately from two plates and combined in the final wash step.
2. After resuspension in 3M medium (step 3.3.11), transfer 6 × 105 protoplasts to each of 5–6 tubes containing 50 μg of DNA (one positive control, one negative
control, and up to four test vectors) and proceed with transformation and selection as described (Roberts et al., 2011).
Complementation assay
1. After the second round of selection, array stably transformed lines (Fig. A3) on plates containing BCDAT medium (Roberts et al., 2011).
2. Incubate at 25°C with fluorescent lights at a photon flux density of 85 μM m−2s−1 for 7 d.
3. To score the cesa5KO phenotype, use a dissecting microscope at 30× to count the number of lines with gametophores. To test complementation of a different
gene, a scoring method can be developed that is appropriate for the mutant phenotype.
4. If necessary, use a compound microscope to further analyze the morphology of specific tissues (protonemal, gametophores, etc.).
Statistics
In the case of the ppcesaR453 mutants, Fisher’s two-tailed exact test (Sokal and Rohlf, 1981), calculated using the 2 × 2 contingency table at http://vassarstats.net/
tab2x2.html, was used to test the significance of test rescue rates vs. rescue rates of the positive and negative controls. However, another test may be more appropriate
depending on how the phenotype is scored.
Microsomal protein extraction
This protocol was modified from Hutton et al. (1998).
1. Collect colonies for protein extraction when they are 0.75–1 cm in diameter (2–3 wk after they are arrayed on BCDAT, Fig. A3D).
• Remove traces of agar and blot colonies firmly with tissue to remove surface water.
• Place each colony in a preweighed 1.5-mL centrifuge tube on ice.
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Fig. A3. Selection of stable transformants. A. Colonies derived from ppcesa5KO-2 protoplasts that survived the first round of antibiotic selection following transformation with a positive control vector that drives constitutive expression of wild-type PpCESA5; stable and unstable transformants are present. B. The plate shown in A after the second round of antibiotic selection showing vigorously growing stable transformants among dead colonies. C. Stable
transformants from the plate shown in B after being arrayed with colonies from two other plates from the same transformation. D. Colonies ready to be
harvested for protein extraction.
• Reweigh tubes to determine tissue weight (expected range 8–12 mg).
• Tissue may be stored at −80°C prior to protein extraction.
• Samples and reagents must remain on ice for the remainder of this protocol.
2. Add 300 μL of extraction buffer to each tube (50 mM HEPES [pH 7.6], 0.1 mM EDTA, 500 mM sucrose, 1 : 100 protease inhibitor cocktail for plant cell lysate,
P9599 [Sigma-Aldrich]).
3. Homogenize tissue using a motor-driven pellet pestle (Z359971, Sigma-Aldrich) until no visible clumps remain.
4. Centrifuge at 10,000 × g, 10 min, 4°C.
5. Collect supernatant and centrifuge at 10,000 × g, 15 min, 4°C.
6. Transfer supernatant to an ultracentrifuge tube and centrifuge at 107,400 × g, 30 min, 4°C.
7. Remove supernatant and resuspend pellet in 32 μL of sample buffer (30 mM Tris [pH 6.8], 2% SDS, 0.00002% bromphenol blue, 10% glycerol).
Protein quantification and normalization
Determine the protein concentrations of microsomal extracts using the Pierce BCA Protein Assay kit (23225, Thermo Scientific Inc., Rockford, Illinois, USA)
according to the manufacturer’s instructions with the following modifications:
• Centrifuge samples and standards for 30 s, 13,000 × g.
• Test 7-μL samples of microsomal extracts (in duplicate) and each standard (expect 500 μg/mL or higher for microsomal extracts).
Western blot
1. Normalize samples to the lowest concentration by adjusting loading volume or adding sample buffer to adjust concentration.
2. Add 10% β-mercaptoethanol to each sample.
3. Run samples (at least 5 μg, but ideally 7–10 μg, total protein) on an SDS-PAGE gel and transfer proteins to a PVDF membrane.
4. Stain membranes with Ponceau S to confirm consistent protein loading (Romero-Calvo et al., 2010). Additional washing with TBST (50 mM Tris [pH 7.5],
150 mM NaCl, 0.05% Tween 20) may be required to remove stain.
5. Probe membrane with an antibody that detects the transgenic protein. Our method follows, but other methods could be used.
• Block membrane in 5% (w/v) milk protein in TBST, 80 rpm, room temperature (RT), 1 h.
• Rinse membrane with TBST.
• Incubate membrane with 1 : 1000 anti-HA (HA.11 Clone 16B120 [BioLegend, Dedham, Massachusetts, USA]) in 5% (w/v) blocking agent in 1× TBST
+ 0.02% sodium azide, 80 rpm, 4°C, 12–16 h.
• Wash membrane in TBST, 80 rpm, 4 min. Repeat three times.
• Incubate membrane in 1 : 4000 HRP-conjugated antimouse (A4416, Sigma-Aldrich), 80 rpm, RT, 1 h.
• Wash membrane in TBST, 80 rpm, 4 min. Repeat three times.
• Develop membrane using Pierce ECL Western Blotting Substrate kit (32106, Life Technologies) according to the manufacturer’s instructions.

APPENDIX 3.

Primers used for sequencing CESA5 entry clones.

Primer
P99
P117
P118
P143
P153
P395
P403
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Sequence
5’-CCCGTTTTTGAAAGGTCTGA-3’
5’-CCTTATTGCAGGCTCACACA-3’
5’-CGTACATCAACGCCACAATC-3’
5’-TTTGGACGATGACTCTCACG-3’
5’-GATTTTGGATCAGTTCCCGA-3’
5’-GAGCTATGGTGGCAATTACGAC-3’
5’-CTTTCTCTCGATTTTCGTGACC-3’
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